Tuhkuri, Anna
Saraswat, Mayank
Mäkitie, Antti
Mattila, Petri
Silén, Robert
Dickinson, Amy
Carpén, Timo
Tohmola, Tiialotta
Joenväärä, Sakari
Renkonen, Suvi
Article History
Received: 14 December 2017
Revised: 14 May 2018
Accepted: 4 June 2018
First Online: 2 July 2018
Ethics approval
: Written informed consent was obtained from all patients. The study plan was approved by the institutional Research Ethics Board at the Helsinki University Hospital (DNr. 51/13/03/02/2013). The current study was performed in accordance with the Declaration of Helsinki.
: The mass spectrometry proteomics is available from the ProteomeXchange Consortium via the PRIDE partner repositorywith the data set identifier PXD008445.
: This study was supported by Korvatautien tutkimussäätiö, Jane and Aatos Erkko Foundation and the University of Helsinki, Medical Faculty.
: The authors declare that they have no competing interests.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).